Koers Pain Therapeutics, Inc. Nasdaq
Aandelen
US69562K1007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | - | Omzet 2025 * | 150 mln. 140 mln. | Marktkapitalisatie | 954 mln. 889 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -96 mln. -89,44 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 6,36 x |
K/w-verhouding 2024 * |
-10,3
x | K/w-verhouding 2025 * |
-46,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01-05-98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01-10-18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01-05-98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01-03-03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers SAVA
- Koers